Averting the Looming Global Pandemic of Type 2 Diabetes: Understanding T2D from the DiRECT, Counterpoint and Counterbalance Research Studies
Prices per Course | NOTE: ACLM members receive an exclusive 20% discount.
Nonmember - $50
Member - $40
1 CME/CNE/CE Credit
1 CPE Credits
(Full Accreditation information listed below)
The possibility of achieving lasting remission of type 2 diabetes, off all hypoglycemic medications, seemed far-fetched - until the last decade. The Counterpoint study established in 2011 that the type 2 diabetes could be reversed to normal glucose control merely by 15kg weight loss. A feasible and well-accepted method of achieving this was developed to test the previously published Twin Cycle Hypothesis of the aetiology of the condition. In 2016, the Counterbalance study demonstrated that reversal to normal depended largely upon duration of type 2 diabetes, and that remission would last at least 6 months provided weight regain was avoided. Then The Diabetes Remission Clinical Study (DiRECT) showed that this could be delivered in routine family practice by regular NHS staff given 8 hours of structured training. This RCT demonstrated that 36% of people with type 2 diabetes remained free of diabetes over 2 years. Further insights into the aetiology and pathophysiology of type 2 diabetes have since been gained. One critically important message for this Lifestyle conference is that substantial weight loss can be achieved by dietary means, but starting new exercise programs must be delayed until after the weight loss has been achieved. This temporal separation of food restriction and new physical activity programs deserves to be widely recognized.
- Describe the simple etiology of type 2 diabetes now understood.
- Discuss how to achieve substantial weight loss using a low calorie diet, temporally separated from increase in physical activity.
- Explain the criteria for remission of type 2 diabetes.
Roy Taylor, BSc, MB ChB, MD, FRCP, FRCPE? – Professor of Medicine and Metabolism, Newcastle University
Dr. Taylor qualified in medicine at the University of Edinburgh, and is Professor of Medicine and Metabolism at Newcastle University and Honorary Consultant at Newcastle Hospitals NHS Trust. He has been conducting research on type 2 diabetes since 1978, and sequentially studied human adipose tissue, fibroblasts, muscle and then liver and whole body. He worked with Professor Gerald Shulman at Yale in 1990-91, and laying the basis for subsequent research. He created the Newcastle Magnetic Resonance Centre in 2006 and has focussed on developing techniques to elucidate how food is handled by the body in health and disease. Recently he has demonstrated the physiological mechanisms whereby type 2 diabetes can be reversed to normal, throwing light on the aetiology of a condition previously regarded as complex and heterogenous. This is described in his book ‘Life Without Diabetes’ published in March 2020 in US.
LM2020 OnDemand sessions are hosted online via the ACLM Learning Management System and each session consists of a title, description, learning objectives, speaker information, video recording, presentation slides in PDF format, an assessment and survey evaluation.
This content can be viewed on a desktop, tablet or mobile device. Speakers or headphones are required.
Term of Approval
February 22, 2021 – February 22, 2023
Access to course: access to online material is granted through the term of approval which ends February 22, 2023.
In support of patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.
Rush University Medical Center designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
ANCC Credit Designation – Nurses The maximum number of hours awarded for this CE activity is 1 contact hour. This activity is being presented without bias and without commercial support.
Rush University Medical Center designates this knowledge based CPE activity for 1 contact hour for pharmacists.
Rush University is an approved provider for physical therapy (216.000272), occupational therapy, respiratory therapy, social work (159.001203), nutrition, speech-audiology, and psychology by the Illinois Department of Professional Regulation. Rush University designates this live activity for 1 Continuing Education credit.
The Commission on Dietetic Registration accepts self-study programs approved through the ACCME.
The American Board of Lifestyle Medicine has approved 1 maintenance of certification credit for this learning activity.
AAFP Prescribed Credits
The AAFP has reviewed LM2020 OnDemand: Health Restored Virtual Conference, and deemed it acceptable for AAFP credit. Term of approval is from 02/23/2022 to 02/23/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session: 1.00 Enduring Materials, Self-Study AAFP Prescribed Credit - Averting the Looming Global Pandemic of Type 2 Diabetes
It is the policy of the Rush University Office of Interprofessional continuing Education to ensure that its CE activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CE. Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months.
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
The course directors, planners and faculty of this activity have stated they have no relevant financial disclosures.